28482688|t|Subjective Cognitive Decline in Preclinical Alzheimer's Disease
28482688|a|Older adults with subjective cognitive decline (SCD) in the absence of objective neuropsychological dysfunction are increasingly viewed as at risk for non-normative cognitive decline and eventual progression to Alzheimer's disease (AD) dementia. The past decade has witnessed tremendous growth in research on SCD, which may reflect the recognition of SCD as the earliest symptomatic manifestation of AD. Yet methodological challenges associated with establishing common assessment and classification procedures hamper the construct. This article reviews essential features of SCD associated with preclinical AD and current measurement approaches, highlighting challenges in harmonizing study findings across settings. We consider the relation of SCD to important variables and outcomes (e.g., AD biomarkers, clinical progression). We also examine the role of self- and informant - reports in SCD and various psychological, medical, and demographic factors that influence the self-report of cognition. We conclude with a discussion of intervention strategies for SCD, ethical considerations, and future research priorities.
28482688	0	28	Subjective Cognitive Decline	T046	C0234985
28482688	32	43	Preclinical	T080	C1709630
28482688	44	63	Alzheimer's Disease	T047	C0002395
28482688	64	76	Older adults	T098	C0001792
28482688	82	110	subjective cognitive decline	T046	C0234985
28482688	112	115	SCD	T046	C0234985
28482688	145	175	neuropsychological dysfunction	T048	C0004936
28482688	215	246	non-normative cognitive decline	T046	C0234985
28482688	260	271	progression	T169	C0449258
28482688	275	294	Alzheimer's disease	T047	C0002395
28482688	296	298	AD	T047	C0002395
28482688	300	308	dementia	T048	C0497327
28482688	361	369	research	T062	C0035168
28482688	373	376	SCD	T046	C0234985
28482688	400	411	recognition	T080	C0205396
28482688	415	418	SCD	T046	C0234985
28482688	435	446	symptomatic	T184	C1457887
28482688	447	460	manifestation	T169	C0205319
28482688	464	466	AD	T047	C0002395
28482688	472	486	methodological	T169	C2700391
28482688	487	497	challenges	T058	C0805586
28482688	534	544	assessment	T058	C0220825
28482688	549	563	classification	T185	C0008902
28482688	564	574	procedures	T169	C2700391
28482688	602	609	article	T170	C1706852
28482688	610	617	reviews	T080	C1704362
28482688	640	643	SCD	T046	C0234985
28482688	660	671	preclinical	T080	C1709630
28482688	672	674	AD	T047	C0002395
28482688	687	698	measurement	T169	C0242485
28482688	699	709	approaches	T169	C1292724
28482688	724	734	challenges	T058	C0805586
28482688	738	755	harmonizing study	T062	C2603343
28482688	756	764	findings	T033	C0243095
28482688	798	806	relation	T080	C0439849
28482688	810	813	SCD	T046	C0234985
28482688	827	836	variables	T080	C0439828
28482688	841	849	outcomes	T169	C1274040
28482688	857	859	AD	T047	C0002395
28482688	860	870	biomarkers	T201	C0005516
28482688	872	880	clinical	T080	C0205210
28482688	881	892	progression	T169	C0449258
28482688	923	928	self-	T062	C2700446
28482688	933	942	informant	T169	C1550484
28482688	945	952	reports	T170	C0684224
28482688	956	959	SCD	T046	C0234985
28482688	972	985	psychological	T041	C0033898
28482688	987	994	medical	T169	C0205476
28482688	1000	1019	demographic factors	T078	C0011292
28482688	1039	1050	self-report	T062	C2700446
28482688	1054	1063	cognition	T041	C0009240
28482688	1098	1121	intervention strategies	T061	C0454040
28482688	1126	1129	SCD	T046	C0234985
28482688	1131	1138	ethical	T078	C0086264
28482688	1139	1153	considerations	T033	C0518609
28482688	1166	1185	research priorities	T062	C0376368